CORPORATE OVERVIEW

Aria Neurosciences, Inc. is a biopharmaceutical company focusing on development and commercialization of novel disease modifying small molecule therapeutics to treat diseases of protein aggregation including Alzheimer's disease and related disorders....

STRATEGY

Aria’s strategy is to tightly focus its efforts on the development of a novel therapeutic for AD, with the goal of demonstrating proof of principle in humans.  Subsequent development and eventual commercialization will be achieved through partnership with an established pharmaceutical or biotechnology company as part of Aria’s exit strategy....

ALZHEIMER'S DISEASE

Worldwide sales of drugs to treat AD approximated $4.3 billion in 2012 (Nature, 2013). The AD drug market is forecast to experience double-digit growth to 2020. The catalysts for this growth include an aging population, earlier and improved diagnosis, and the introduction of therapies that can be prescribed in addition to existing treatments....

CONTACT

 

Aria Neurosciences, Inc.

295 Washington Ave, Suite 4N

Hamden, CT 06518

Tel:(203) 815-5782

www.arianeurosciences.com

Alzheimer's Disease

Copyright © 2013 Aria Neurosciences, Inc.

I

I

I